Multifunctional Oxygenated Particles for Targeted Cancer Drug Delivery and Evaluation with Darkfield Hyperspectral Imaging
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multifunctional Oxygenated Particles for Targeted Cancer Drug Delivery and Evaluation with Darkfield Hyperspectral Imaging
Authors
Keywords
-
Journal
ACS Omega
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2022-11-01
DOI
10.1021/acsomega.2c04953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperspectral dark-field microscopy for pathogen detection based on spectral angle mapping
- (2022) Lingyan Zheng et al. SENSORS AND ACTUATORS B-CHEMICAL
- Multifunctional Nanocarriers for Lung Drug Delivery
- (2020) Jorge F. Pontes et al. Nanomaterials
- Monomeric cohesin state revealed by live‐cell single‐molecule spectroscopy
- (2019) Wenjie Liu et al. EMBO REPORTS
- Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy
- (2018) Pushpak Bhandari et al. Scientific Reports
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- A Smart Nano-Prodrug Platform with Reactive Drug Loading, Superb Stability, and Fast Responsive Drug Release for Targeted Cancer Therapy
- (2017) Hao Meng et al. MACROMOLECULAR BIOSCIENCE
- A review of drug release mechanisms from nanocarrier systems
- (2017) Chizhu Ding et al. Materials Science & Engineering C-Materials for Biological Applications
- Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
- (2017) Kentaro Inamura Frontiers in Oncology
- Oxygen nanobubbles revert hypoxia by methylation programming
- (2017) Pushpak N. Bhandari et al. Scientific Reports
- Optical Clearing Delivers Ultrasensitive Hyperspectral Dark-Field Imaging for Single-Cell Evaluation
- (2016) Yi Cui et al. ACS Nano
- The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
- (2016) Nazanin Hoshyar et al. Nanomedicine
- Doxorubicin loaded dual pH- and thermo-responsive magnetic nanocarrier for combined magnetic hyperthermia and targeted controlled drug delivery applications
- (2016) Aziliz Hervault et al. Nanoscale
- Fluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycin
- (2016) Najme Sadat Hosseini Motlagh et al. Biomedical Optics Express
- The Clinical Significance of Hypoxia in Human Cancers
- (2015) Neesha Dhani et al. SEMINARS IN NUCLEAR MEDICINE
- State-of-the-art materials for ultrasound-triggered drug delivery
- (2014) Shashank R. Sirsi et al. ADVANCED DRUG DELIVERY REVIEWS
- Quantitative imaging of single mRNA splice variants in living cells
- (2014) Kyuwan Lee et al. Nature Nanotechnology
- Hyperspectral darkfield microscopy of PEGylated gold nanoparticles targeting CD44-expressing cancer cells
- (2013) Sergiy Patskovsky et al. Journal of Biophotonics
- Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
- (2013) Chee Khoon Lee et al. JNCI-Journal of the National Cancer Institute
- Detection, Characterization, and Abundance of Engineered Nanoparticles in Complex Waters by Hyperspectral Imagery with Enhanced Darkfield Microscopy
- (2012) Appala Raju Badireddy et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Folic Acid Protected Silver Nanocarriers for Targeted Drug Delivery
- (2012) Yuling Wang et al. Journal of Biomedical Nanotechnology
- Fluorescence Lifetime Cross Correlation Spectroscopy Resolves EGFR and Antagonist Interaction in Live Cells
- (2010) Jiji Chen et al. ANALYTICAL CHEMISTRY
- Multimodal drug delivery using gold nanoparticles
- (2009) Chae-kyu Kim et al. Nanoscale
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started